CCG-203971
CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
408.88
Molecular Formula
C23H21ClN2O3
Notes
Research use only, not for human use.
Receptor
Others
CAS Number
1443437-74-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
